Clinical Trials Browser

Phase 2 × Sarcoma × trebananib × Clear all

NCT01623869 2015-10-19

Trebananib in Treating Patients With Advanced Angiosarcoma That Cannot Be Removed by Surgery

Phase 2 Completed

16 enrolled 6 charts

Hemangiosarcoma, Sarcoma